Scintillant Bioscience Revenue and Competitors

Scintillant Bioscience is a contract research organization (CRO), conducting early-stage drug discovery research for our clients. We develop, validate and implement drug-discovery assays, with emphasis on high content imaging (HCI)/high content screening (HCS)/high content analysis (HCA) services. We are happy to work with you on any of your needs for biochemical or cell-based assay development, validation or implementation. We have developed drug-discovery assays using primary cells, cell lines and iPSC-derived cell types. We will custom build stably overexpressing-, mutant- or reporter-gene cell lines as required for your drug-discovery programs. Let us help with your drug-discovery challenges.